“Multiple myeloma red flag”的搜索结果，显示 131-140 项，共有 11009 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able to ...

2. 血液科- 临床试验- 妙佑医疗国际

   Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...

3. 血液科- 临床试验- 妙佑医疗国际

   Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...

4. 血液科- 临床试验- 妙佑医疗国际

   ... Multiple Myeloma (MM). This study includes 2 parts; step-up dose ... Multiple Myeloma That is Resistant to Current Standard of Care Treatments.

5. 血液科- 临床试验- 妙佑医疗国际

   Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...

6. Mayo Clinic Neurosciences Physician Update � May 2026

   Page 1.

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able to ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study To Examine The Effects Of Novel Therapy Linvoseltamab In Combination With Other Cancer Treatments For Adult Patients With Multiple Myeloma That Is ...

9. 血液科- 临床试验- 妙佑医疗国际

   Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...

10. 血液科- 临床试验- 妙佑医疗国际

    This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.